All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Olympia Pharmaceuticals

503A Outsourcing Facility — FDA safety data from public records

By FormBlends Editorial Team·

On This Page

OverviewCompany SnapshotProfile AnalysisRisk SummaryCompliance AnalysisFDA RegistrationWarning LettersRecallsAdverse EventsPatient ChecklistRelated FDA ActionsSimilar CompaniesSafety ComparisonsPrimary Sources
FDA Registered503A Outsourcing Facility503B Facility

FDA-registered 503B outsourcing facility specializing in sterile compounding across GLP-1 medications, hormone therapy, and other specialty formulations.

Website: olympiapharmacy.com

Data last verified: 2026-04-25

Company Snapshot

Entity Type

503A Outsourcing Facility

FDA Registration

active

Warning Letters

0

Recalls

0

States Licensed

Not listed

Compounding Status

503B

What This Company Profile Actually Tells You

Olympia Pharmaceuticals is categorized here as a 503B outsourcing facility or closely related sterile compounding operation. That matters because 503B facilities occupy a different regulatory lane than telehealth brands: they are physical drug establishments with FDA-facing registration obligations and manufacturing-style oversight expectations.

Olympia Pharmaceuticals's exact geographic footprint is not summarized on this page, so readers should confirm state availability before assuming access in their market. Readers evaluating a 503B facility should care about sterility controls, batch processes, inspection history, recalls, and whether the facility role being marketed to the public matches the legal operating status reflected in FDA records.

From a search and trust perspective, these pages need to answer a more technical question than a typical company review. Users are not just deciding whether they like the brand. They are trying to understand whether the facility is properly registered, how it is classified, and what public safety signals exist around its operations.

Olympia Pharmaceuticals Background

Market Position

Olympia is a recognizable facility-level name in the compounding and outsourcing segment, most relevant when patients or providers are tracing where medication is actually coming from.

Business Model

As a 503B outsourcing facility, Olympia should be evaluated like a production and fulfillment site, not like a telehealth front end. Registration status, quality controls, and public enforcement history matter more than consumer-brand aesthetics.

Pharmacy And Supply Notes

If Olympia appears as a fulfillment partner in a telehealth workflow, patients should treat that as a clue to investigate the facility's public record, not as the end of the diligence process.

Consumer Risk Notes

A visible FDA registration record is useful, but the most practical questions still concern lot controls, shipping integrity, and whether the downstream provider explains the fulfillment chain clearly.

Key Facts

Olympia is a facility-level player in the supply chain rather than a consumer-facing telehealth brand.

Its active registration gives patients something concrete to verify in public records.

Facility visibility helps, but patients should still ask for precise sourcing and quality documentation.

Risk Summary

No FDA warning letters are currently shown in this profile.

No recall events are currently shown in the FDA enforcement data surfaced here.

FDA registration status is shown as active.

Compounding status is listed as 503B.

3 adverse event reports are summarized, including 0 serious reports.

Regulatory And Compliance Analysis

Registration Context

Olympia Pharmaceuticals shows an active FDA registration record in the establishment database. That is a useful signal for facility verification, but it should still be read as registration data rather than a product approval or quality guarantee.

Warning Letter Readout

We did not find FDA warning letters for Olympia Pharmaceuticals in this profile. That is better than the alternative, but it is not a blanket endorsement. A clean warning-letter record only tells you that this page is not currently surfacing a published FDA warning letter tied to the entity.

Recall Readout

No recall events are shown for Olympia Pharmaceuticals here. For consumers, that lowers one category of concern, but it still does not replace verification of sourcing, labeling, temperature handling, and pharmacy quality controls.

Adverse Event Context

Olympia Pharmaceuticals is associated here with 3 adverse event reports, of which 0 are marked serious. FAERS-style reporting can surface patterns worth attention, but these reports alone do not prove the company caused the event.

FDA Registration

Status
FDA Registered
FEI Number
3011788392
Facility Type
503B Outsourcing Facility
Last Verified
2026-04-10

Source: FDA Drug Establishment Registration & Listing

FDA Warning Letters (0)

No FDA warning letters are currently shown for Olympia Pharmaceuticals in this profile. That is helpful context, but users should still verify current marketing claims, pharmacy sourcing, and how the company describes compounded medications.

Recall History (0)

No recalls are currently displayed for Olympia Pharmaceuticals in the openFDA enforcement data surfaced on this page. That lowers one obvious risk signal, but it should not be treated as proof that all products, batches, or fulfillment practices are problem-free.

Source: openFDA Drug Enforcement API

Adverse Event Reports

3

Total Reports

0

Serious Reports

Q4 2025

Data Through

Most Reported Reactions

Injection site reaction (2)

Source: FDA Adverse Event Reporting System (FAERS). Adverse event reports do not establish causation.

Questions Patients Should Ask Before Using Olympia Pharmaceuticals

Can Olympia Pharmaceuticals confirm the exact facility name, operating status, and whether the prescription will be filled under a 503A or 503B framework?

What does Olympia Pharmaceuticals tell patients about compounded versus FDA-approved products, and does that language avoid implying equivalence or approval where it does not exist?

How does Olympia Pharmaceuticals handle dose escalations, refill delays, refunds, cancellations, and temperature-sensitive shipping problems?

If a patient has a side effect or receives a product-quality concern, what is the human escalation path and how quickly does Olympia Pharmaceuticals respond?

Can Olympia Pharmaceuticals provide lot-level documentation, pharmacy details, and a clear explanation of what safety checks happen before medication is dispensed?

Similar Companies

These related profiles are useful for searchers comparing Olympia Pharmaceuticals against adjacent providers or pharmacies. Reading similar pages side by side usually reveals whether a concern is unique to one company or common across this category.

Empower Pharmacy

503A Outsourcing Facility

Hallandale Pharmacy

503A Outsourcing Facility

Valor Compounding Pharmacy

503A Outsourcing Facility

Pavilion Compounding Pharmacy

503A Outsourcing Facility

How To Use This Profile

This profile organizes public-source safety signals for Olympia Pharmaceuticals, including FDA registration status, warning letters, recalls, and any adverse event summary data available in the dataset.

A company can appear relatively clean here and still deserve more diligence, because absence of a warning letter or recall is not the same as proof of quality.

For 503a outsourcing facility pages especially, readers should distinguish between the consumer-facing brand and the pharmacy or facility that actually handles medication production or dispensing.

Primary Sources And Verification Links

Use these links to validate the key claims in this profile and to separate the consumer-facing brand story from the underlying regulatory record.

Olympia Pharmaceuticals official website

Primary facility website used to verify identity and the 503B outsourcing-facility positioning used in this profile.

Open source

Olympia 503B knowledge-center page

Supports the 503B facility-role framing used in this profile.

Open source

FDA Drug Establishment Registration & Listing

Verification path for the active FDA establishment registration information shown here.

Open source
Olympia Pharmaceuticals official websiteOpen sourceFDA Adverse Event Reporting System (FAERS)Open source

Looking for a Verified GLP-1 Provider?

FormBlends partners with licensed 503A compounding pharmacies. Every compound is third-party tested with certificates of analysis.

Learn More

Disclaimer: This page aggregates publicly available data from the FDA, state pharmacy boards, and other government sources. It is provided for informational purposes only and does not constitute medical or legal advice. FDA registration does not imply FDA approval or endorsement. The absence of warning letters or recalls does not guarantee safety or quality. Always consult your healthcare provider before making decisions about medications. Data may not reflect the most current status. Last updated: 2026-04-25.

Safety Guides

503A vs 503B pharmacies

Understanding the FDA oversight difference.

How to read a Certificate of Analysis

What every CoA should include and red flags to watch for.

What FDA registration actually means

Registration vs approval: the distinction most people miss.

Choosing a compounding pharmacy

What to verify before you fill your first prescription.

GLP-1 Safety Alerts

Get notified when the FDA issues warning letters, recalls, or regulatory updates affecting GLP-1 medications and compounding pharmacies.

Free. No spam. Unsubscribe anytime.

Frequently Asked Questions

Is Olympia Pharmaceuticals FDA registered?

Olympia Pharmaceuticals is currently registered with the FDA. Registration status was last verified on 2026-04-10. Note that FDA registration does not imply FDA approval or endorsement.

Has Olympia Pharmaceuticals received any FDA warning letters?

We have not found any FDA warning letters issued to Olympia Pharmaceuticals in our records. This page is updated regularly as new FDA data becomes available.

Does Olympia Pharmaceuticals have any recalls?

We have not found any recalls associated with Olympia Pharmaceuticals in the openFDA enforcement database.

Is Olympia Pharmaceuticals a telehealth company or a pharmacy?

Olympia Pharmaceuticals is categorized in this profile as a 503a outsourcing facility. That distinction matters because a telehealth brand, a 503A pharmacy, and a 503B outsourcing facility operate under different regulatory expectations.

Does a clean profile mean Olympia Pharmaceuticals is definitely safe?

No. A clean profile means we are not currently surfacing certain FDA signals like warning letters or recalls for Olympia Pharmaceuticals. It does not guarantee product quality, customer-service quality, or future regulatory compliance.

What should patients verify before using Olympia Pharmaceuticals?

Patients should verify who is prescribing, which pharmacy or outsourcing facility is actually fulfilling the medication, what the company says about compounded versus FDA-approved products, and how billing, cancellations, and side-effect escalation are handled.